Results 1 to 3 of about 8 (3)
Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet [PDF]
Nefrología (English Edition), 2023 Introduction: There is scarce clinical experience with etelcalcetide in patients with secondary hyperparathyroidism uncontrolled with cinacalcet. The effect of etelcalcetide on serum sclerostin levels remains to be clarified.
Luciano Artur Lopes Pereira +6 more
doaj +4 more sources
Etelcalcetide: What we know eight years since its approval [PDF]
Nefrología (English Edition)Introduction and objectives: The impact of etelcalcetide on patients with chronic kidney disease (CKD) and secondary hyperparathyroidism (SHPT) has been studied since its introduction in 2016/2017.
Pedro Freitas, Luciano Pereira
doaj +6 more sources
Sodium thiosulfate and pamidronate for treatment of calciphylaxis: case report. [PDF]
Colomb Med (Cali), 2018 Fernández Cañabate S +3 more
europepmc +1 more source